infection. A final diagnosis of hamartomatous lesion favoring NCH (with superficial fungal infection) was offered. Immunohistochemistry (IHC) was performed. The melanocytic cells showed strong positivity for S100 protein. They were also positive for HMB-45 [ Figure 5 ]. Spindle-shaped cells in the connective tissue were positive for CD34 [ Figure 6 ]. Ki-67 labeling did not show any significant proliferation. IHC supported the histopathological diagnosis of NCH. Postprocedure period was uneventful, and the patient was stable.
dIscussIon
NCH is a rare hamartomatous skin lesion, presumably resulting from aberrant development of neuromesenchyme. [3, 4] The elements of NCH reflect the spectrum of differentiation inherent in neural crest-derived cells. [3] The lesion can harbor neurosustenticular and neuromesenchymal components. [4] resembling dermatophytes [ Figure 2 ]. Subepithelium showed sebaceous glands, focal granulation tissue response consisting of congested blood vessels, fibroblastic proliferation, and chronic inflammatory cell infiltrate. Inflammatory cell infiltrate was composed of predominantly lymphocytes, few plasma cells, mast cells, and macrophages. Also seen were mesenchymal elements composed of lobules of adipocytes, bundles of smooth muscle tissue, and bone tissue displaying mineralization front [ Figure 3 ]. Ectodermal derivative composed of nerve bundles and melanocytes were seen. Melanocytes were seen arranged in clusters, nests, and theques [ Figure 4 ]. Melanocytes showed epithelioid morphology in the superficial dermis lymphoid morphology in the mid-dermis and Schwannoid (spindle cell) morphology in the deeper dermis. Epithelioid melanocytic cells showed cytoplasmic pigmentation. There was no evidence of malignancy or junctional activity. Features were suggestive of a harmartomatous lesion with superficial fungal (dermatophytes) They may be congenital or acquired. [1, 3, 5] NCH typically present later in childhood and more commonly in the adulthood, probably due to slower progression of the lesion. [6] Most NCH has a predilection for the scalp. However, few cases have been reported on the back, trunk, and extremities. [1.3] Clinically, they may present as pigmented macules, papules, or nodules with or without alopecia. [1] In the present case, the lesion was seen in a 29-year-old female, presenting as a pedunculated swelling in the lower back, which was an unusual location for the lesion.
The NCH consists of a combination of elements including nevomelanocytes, pigmented dendritic cells, Schwann cells, spindle cells, and fibroblasts. Thus, the pluripotent nature of neural crest cells is underscored. These lesions also contain neurosustenticular and neuromesenchymal cells. Dermal melanocytes are present in NCH but are unassociated with a junctional element. [3] In the present case, NCH was composed of ectodermal derivative tissue and mesenchymal elements. Ectodermal derivative tissue included melanocytes displaying normal maturation pattern. Previous literature documented similar histomorphological features in their case reports. [1] [2] [3] The presence of bone tissue as a part of the mesenchymal component and presence of superficial fungal infection contributed to the uniqueness of the lesion. In contrast, Conrad et al. [4] reported bone marrow involvement and Denlinger et al. [5] observed skeletal muscle involvement in their case reports. Other documented features of NCH include a prominent collection of melanocytes around hair follicles, eccrine glands, nerves and blood vessels, perivascular pseudorosettes, and tactoid bodies. [1] Occasionally, NCH may occur in the setting of other neural crest-derived disorders such as neurofibromatosis and neurocutaneous melanosis. [3] The melanocytic cells showed strong positivity for S100 protein. They were also positive for HMB-45. Spindle-shaped cells in the connective tissue were positive for CD34. Lee et al. [1] and Kim et al . [2] also documented similar immunophenotypic characteristics. Baskara et al. [7] observed that the lesion was positive for S100, microphthalmia-associated transcription factor, melan A, tyrosinase, CD34, and HMB45. NCH has to be differentiated from congenital nevi, blue nevi, and nerve sheath tumors (Schwannoma and neurofibroma). In NCH, the surrounding stroma and stroma with Schwannian differentiation show increased CD34-positive cells. Increased CD34 staining is seen in neurally derived tumors and marks a subset of endoneurally derived cells. [3] Congenital nevi and blue nevi do not show stromal staining for CD34. [2, 3] In neurofibromas and Schwannomas, the presence of abundant mast cells, marked hyperplasia of overlying epidermis, and papillomatosis is the differentiating features. [3] Although the course of NCH is generally indolent, long-standing NCH has been reported to give rise to cutaneous malignant neurocristic tumors. [1] The time period for the development of malignant tumor has been estimated to be 1-6 years for acquired NCH and 15-67 years for congenital NCH. [1, 2] The importance of recognizing NCH is due to the possible transformation to malignant melanoma over an unpredictable period of time. [2] Approximately 25%-33% of cutaneous melanomas arise from nevi. Junctional and compound nevi may be relatively more likely to give rise to melanoma than intradermal nevi. [8] NCH develops into malignant melanoma because these tumors exhibit melanocytic differentiation and arise in hamartomatous lesions composed of neural crest derivatives. [9] Factors affecting the risk and onset of malignant NCH transformation are still unknown. [1] Malignant NCH shows a less aggressive behavior than conventional malignant melanoma. Malignant tumors are usually circumscribed, multinodular lesions which tend to recur as bulky nodules and metastasize after years or decades. Patients may experience multiple recurrences and hematogeneous spread. BRAF, NRAS, GNAQ, or KIT mutations are not found in malignant NCH, suggesting that malignant NCH may be distinct from conventional melanoma. [1] Due to a small number of cases reported, no guidelines are available for the management of NCH. [1, 3] It has been suggested that wide local excision should be considered to reduce the malignant potential. [1] [2] [3] Complete excision of the lesion is crucial as it prevents likely development of melanoma. [1, 2, 7] Early diagnosis is useful for the proper management of NCH. The optimum management should also include long-term follow-up and surveillance for the development of malignant melanoma. [2] conclusIon NCH is a rare entity and poses a diagnostic challenge. Clinically, the lesion poses a diagnostic dilemma. IHC may be helpful, but a pathologist has to primarily depend on the histopathological characteristics of the lesion for diagnosing the condition.
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